Journal of Medical Case Reports
July 13, 2026
Kei Torii, Ryo Nishitani
Altered-state phenomenology around ketamine may relate to longer-term changes in imaginal processes, but observations across routine care are scarce. We report an educational case focusing on pre-defined dream motifs over time, without making treatment efficacy claims. A 48-year-old Japanese man with severe chronic primary low back pain reported dreams during insight-oriented psychotherapy from...
Journal of Medical Case Reports
December 24, 2024
S Asad, K Latifzai, V T Eliopoulos et al.
1 citation
Ketamine treatment presents a novel approach for addressing refractory conditions, such as major depressive disorder, suicidal ideation, and posttraumatic stress disorder, which often co-occur and pose significant challenges for clinicians. This study explores the clinical and electrophysiological outcomes of ketamine treatment in two cases, shedding light on its potential efficacy and...
Journal of Medical Case Reports
March 3, 2024
Alireza Teymouri, Hadis Nasoori, Maryamsadat Fakheri et al.
20 citations
Anesthesiologists prefer ketamine for certain surgeries due to its effectiveness as a non-competitive inhibitor of the N-methyl-D-aspartate receptor in the brain. Recently, this agent has also shown promise as an antidepressant. However, ketamine can cause hallucinogenic effects and is sometimes abused as an illicit drug. Ketamine abuse has been associated with liver and bile duct...
Journal of Medical Case Reports
October 15, 2023
Dan Bolton, Tegest Hailu, Christina A. Porucznik
2 citations
Abstract Background Stuttering may include repetition of words in whole or part, difficulty saying words, and elongated pauses in speech. Approximately 5% of children stutter for a period lasting 6 months or more. Most of those children stop stuttering as they approach adulthood, but the condition persists in approximately 1% of adults. The cause of stuttering is unknown. Adults who stutter...
Journal of Medical Case Reports
September 23, 2023
Tianyi Hui, Song Guo
2 citations
Current evidence linking the development of Parkinson's disease after the use of 3,4-methylenedioxymethamphetamine is mixed and limited, with only a few positive case reports demonstrating this. We examine this interesting case of a 49-year-old Chinese gentleman who used 3,4-methylenedioxymethamphetamine and subsequently developed early onset Parkinson's disease at age 38 years. He had a family...
Journal of Medical Case Reports
October 31, 2015
Lorenz Breuer, Burkhard S Kasper, Bernd Schwarze et al.
16 citations
Misuse of various new psychotropic substances such as ibogaine is increasing rapidly. Knowledge of their negative side effects is sparse. We present a case of intoxication with the herbal substance ibogaine in a 22-year-old white man. After taking a cumulative dose of 38 g (taken in two doses), he developed visual memories, nausea and vomiting. He developed a generalized tonic-clonic seizure...
Journal of Medical Case Reports
June 18, 2014
Trupti Vakde, M. Díaz, Kalpana Uday et al.
16 citations
Introduction“Molly” is a street name for pure 3,4-methylenedioxymethamphetamine, an amphetamine derivative which acts by enhancing the release of neurotransmitters such as serotonin, dopamine and norepinephrine. This produces euphoria, increased sensory awareness and central stimulation that make it a popular club drug. Nevertheless, it is also associated with serious side effects. We report an...
Journal of Medical Case Reports
December 10, 2009
Amr A Guenedi, Ala'Alddin Al Hussaini, Yousif A Obeid et al.
9 citations
The view that spirits may possess humans is found in 90% of the world population, including Arab/Islamic societies. Despite the association between possessive states and various neurological and psychiatric disorders, the available literature has yet to correlate possessive states with functional brain imaging modalities such as single-photon-emission computed tomography. This paper describes...